Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Zoledronic Acid in Prostate Cancer with Bone Metastases
NCT00242554Phase 4Completed
- Sponsor
- Novartis
- Start
- Oct 2002
- Primary completion
- Jul 2007
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of zoledronic acid in bone metastases, sponsored by Novartis. Started Oct 2002; status: completed.
02
Drugs
zoledronic acid
03
Conditions
bone metastases
Beyond the preview
Go deeper on NCT00242554.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00242554.